Grimes & Company, Inc. Dexcom Inc Transaction History
Grimes & Company, Inc.
- $3.93 Billion
- Q3 2025
A detailed history of Grimes & Company, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Grimes & Company, Inc. holds 116,500 shares of DXCM stock, worth $8.23 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
116,500
Previous 134,054
13.09%
Holding current value
$8.23 Million
Previous $11.7 Million
33.01%
% of portfolio
0.2%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding DXCM
# of Institutions
1,107Shares Held
370MCall Options Held
5.32MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$3.41 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.44 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.19 Billion0.06% of portfolio
-
Baillie Gifford & CO16.7MShares$1.18 Billion1.14% of portfolio
-
Jennison Associates LLC11.5MShares$813 Million0.6% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...